This inventor holds 1 USPTO granted patent. Top assignees: Glaxo Group Limited, King's College London, Vanderbilt University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,170 
1 out of 196 
1 out of 1,226 
Years Active: 2019
Title: Iain Tough: Innovator in Melanocortin Receptor Modulation
Introduction
Iain Tough is a notable inventor based in London, GB. He has made significant contributions to the field of biochemistry, particularly in the development of positive allosteric modulators for the human melanocortin-4 receptor. His work has implications for various therapeutic applications.
Latest Patents
Iain Tough holds a patent for "Positive allosteric modulators of human melanocortin-4 receptor." This patent discloses positive allosteric modulators of the melanocortin receptor and methods for utilizing these modulators. His innovative approach has the potential to advance treatment options in related medical fields.
Career Highlights
Throughout his career, Iain Tough has been associated with prestigious institutions such as Vanderbilt University and King's College London. His work at these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Iain has worked alongside notable colleagues, including Julien A Sebag and Lawrence A Wolfe. Their combined expertise has fostered advancements in the understanding and application of melanocortin receptor modulation.
Conclusion
Iain Tough's contributions to the field of biochemistry, particularly through his patent on melanocortin receptor modulators, highlight his role as an innovator. His work continues to influence research and therapeutic strategies in this important area of study.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile